Spirig HealthCare AG - Nilotinib Spirig HC 150 mg, Hartkapseln | | 69771 | | 02 | | Nilotinib Spirig HC 150 mg | | Hartkapseln | | L01X | | Other Antineoplastic Agents | | 16.04.2025 | | |
| Composition | nilotinibum 150 mg ut nilotinibi hydrochloridum dihydricum, lactosum monohydricum 109.97 mg, crospovidonum, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: hypromellosum, aqua purificata, carrageenanum, kalii chloridum, E 127, E 172 (flavum), E 172 (rubrum), E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula. | Packungsbestandteile | | Capsules | | Active Agent | Dose |
---|
Nilotinibum | 150 mg |
| | Inactive agents | Dose | additional_information |
---|
(Flavum) | | | (Nigrum) | | | (Rubrum) | | | Aqua Purificata | | | Carrageenanum | | | Crospovidonum | | | E 127 | | color. | E 171 | | color. | E 172 | | color. | Hypromellosum | | Kapselhülle | Potassium Chloride | | | Kalii Hydroxidum | | | Lacca | | Drucktinte | Lactose Monohydrate | 109.97 mg | | Magnesii Stearas | | | Pro Capsula | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
002 | 112 | PR | PR | A | | No |
|
|